Public Comment and Testimony

Public Comment Regarding the World Health Organization's Hepatitis Report

May 9, 2014

Public Comment by Carl Scmid, Deputy Executive Director of The AIDS Institute, before the Stakeholder Listening Session in Preparation for the 67th World Health Assembly, HHS Click here to read the comments. 

Written Testimony to the House Appropriations Subcommittee on Labor, Health and Human Services

March 28, 2014

"We have made great progress, but we are still far from achieving our goal of an AIDS-free generation. We now have the tools, but we need continued leadership and the necessary resources to realize our goal."  Read the testimony here. 

The AIDS Institute Testifies Against Proposal to Restrict Medications in Medicare Part D

February 26, 2014

Carl Schmid, Deputy Executive Director of The AIDS Institute, urged CMS “to scrap the proposal to change the ‘six protected classes.’”

The AIDS Insititute Makes Public Comment Before the Presidential Advisory Council on HIV/AIDS

February 28, 2014

The AIDS Institute urged the PACHA to weigh in with the Administration to issue further guidance to implement the anti-discrimination protections in the ACA and to take action to enforce them, as well as urge CMS to scrap the proposed changes to the Medicare Part D "six protected classes." Read the comments here.

The AIDS Institute Comments Before the Presidential Advisory Council on HIV/AIDS

September 25, 2013

“While it will be important to analyze the impact of health reform on Ryan White as a whole, doing so with respect to diverse communities and across geographic regions will be critical to addressing health disparities.”

Click here to read the comments.

The AIDS Institute Testimony to the Senate Appropriations Health Subcommittee

May 6, 2013

"With all these positive developments it would be a shame to go backwards, but that is what could happen given the sequestration and budget cuts that are impacting the Ryan White Program at HRSA, HIV and Hepatitis prevention programs at the CDC, and research at the NIH."

Click here to read the testimony.

Syndicate content